The role of obesity, different fat compartments and sleep apnea severity in circulating leptin levels: The Icelandic Sleep Apnea Cohort study

International Journal of Obesity

Volumn 37, Issue 6, 2013, Pages 835-842

  Arnardottir, E S ^a,b,c   Maislin, G ^c   Jackson, N ^c   Schwab, R J ^c   Benediktsdottir, B ^a,b   Teff, K ^d,e   Juliusson, S ^a   Pack, A I ^b,c   Gislason, T ^a,b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d MONELL CHEMICAL SENSES CENTER   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

adipokine; hypertension; leptin; obstructive sleep apnea; subcutaneous fat; visceral fat

Indexed keywords

LEPTIN;

ABDOMINAL FAT; ADULT; AGED; APNEA HYPOPNEA INDEX; ARTICLE; BODY FAT; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENDER; HUMAN; HYPERTENSION; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIORITY JOURNAL; SLEEP; SLEEP DISORDERED BREATHING; SUBCUTANEOUS FAT;

EID: 84882245368     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2012.138     Document Type: Article

References (64)

1. Bravo PE, Morse S, Borne DM, Aguilar EA, Reisin E. Leptin and hypertension in obesity. Vasc Health Risk Manag 2006; 2: 163-169.
2. Ciccone M, Vettor R, Pannacciulli N, Minenna A, Bellacicco M, Rizzon P et al. Plasma leptin is independently associated with the intima-media thickness of the common carotid artery. Int J Obes Relat Metab Disord 2001; 25: 805-810.
3. Paolisso G, Tagliamonte MR, Galderisi M, Zito GA, Petrocelli A, Carella C et al. Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men. Hypertension 1999; 34: 1047-1052.
4. Arnardottir ES, Mackiewicz M, Gislason T, Teff KL, Pack AI. Molecular signatures in obstructive sleep apnea in adults: a review and perspective. Sleep 2009; 32: 447-470.
5. Al Lawati N, Mulgrew A, Cheema R, vanEeden S, Butt A, Fleetham J et al. Pro-atherogenic cytokine profile of patients with suspected obstructive sleep apnea. Sleep Breath 2009; 13: 391-395.
6. Basoglu OK, Sarac F, Sarac S, Uluer H, Yilmaz C. Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome. Ann Thorac Med 2011; 6: 120-125.
7. Ip MS, Lam KS, Ho C, Tsang KW, Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 2000; 118: 580-586.
8. Kapsimalis F, Varouchakis G, Manousaki A, Daskas S, Nikita D, Kryger M et al. Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea. Lung 2008; 186: 209-217.
9. Makinodan K, Yoshikawa M, Fukuoka A, Tamaki S, Koyama N, Yamauchi M et al. Effect of serum leptin levels on hypercapnic ventilatory response in obstructive sleep apnea. Respiration 2008; 75: 257-264.
10. McArdle N, Hillman D, Beilin L, Watts G. Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 2007; 175: 190-195.
11. Ozturk L, Unal M, Tamer L, Celikoglu F. The association of the severity of obstructive sleep apnea with plasma leptin levels. Arch Otolaryngol Head Neck Surg 2003; 129: 538-540.
12. Patel SR, Palmer LJ, Larkin EK, Jenny NS, White DP, Redline S. Relationship between obstructive sleep apnea and diurnal leptin rhythms. Sleep 2004; 27: 235-239.
13. Phillips BG, Kato M, Narkiewicz K, Choe I, Somers VK. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 2000; 279: H234-H237.
14. Tatsumi K, Kasahara Y, Kurosu K, Tanabe N, Takiguchi Y, Kuriyama T. Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. Chest 2005; 127: 716-721.
15. Tokuda F, Sando Y, Matsui H, Koike H, Yokoyama T. Serum levels of adipocytokines, adiponectin and leptin, in patients with obstructive sleep apnea syndrome. Intern Med 2008; 47: 1843-1849.
16. Ulukavak Ciftci T, Kokturk O, Bukan N, Bilgihan A. Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome. Respiration 2005; 72: 395-401.
17. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000; 85: 1151-1158.
18. Zirlik S, Hauck T, Fuchs FS, Neurath MF, Konturek PC, Harsch IA. Leptin obestatin and apelin levels in patients with obstructive sleep apnoea syndrome. Med Sci Monit 2011; 17: CR159-CR164.
19. Chin K, Shimizu K, Nakamura T, Narai N, Masuzaki H, Ogawa Y et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 1999; 100: 706-712.
20. Chin K, Nakamura T, Takahashi K, Sumi K, Ogawa Y, Masuzaki H et al. Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients. Am J Med 2003; 114: 370-376.
21. Cuhadaroglu C, Utkusavas A, Ozturk L, Salman S, Ece T. Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea. Lung 2009; 187: 75-81.
22. Harsch IA, Konturek PC, Koebnick C, Kuehnlein PP, Fuchs FS, Pour Schahin S et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 2003; 22: 251-257.
23. Saarelainen S, Lahtela J, Kallonen E. Effect of nasal CPAP treatment on insulin sensitivity and plasma leptin. J Sleep Res 1997; 6: 146-147.
24. Shimizu K, Chin K, Nakamura T, Masuzaki H, Ogawa Y, Hosokawa R et al. Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome. Thorax 2002; 57: 429-434.
25. Trenell MI, Ward JA, Yee BJ, Phillips CL, Kemp GJ, Grunstein RR et al. Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. Diabetes Obes Metab 2007; 9: 679-687.
26. Drummond M, Winck JC, Guimaraes JT, Santos AC, Almeida J, Marques JA. Autoadjusting-CPAP effect on serum leptin concentrations in obstructive sleep apnoea patients. BMC Pulm Med 2008; 8: 21.
27. Papaioannou I, Patterson M, Twigg GL, Vazir A, Ghatei M, Morrell MJ et al. Lack of association between impaired glucose tolerance and appetite regulating hormones in patients with obstructive sleep apnea. J Clin Sleep Med 2011; 7: 486-92B.
28. Sanchez-de-la-Torre M, Mediano O, Barcelo A, Pierola J, de la Pena M, Esquinas C et al. The influence of obesity and obstructive sleep apnea on metabolic hormones. Sleep Breath 2011; e-pub ahead of print 13 September 2011.
29. Schafer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, Berthold HK. Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 2002; 122: 829-839.
30. Sharma SK, Kumpawat S, Goel A, Banga A, Ramakrishnan L, Chaturvedi P. Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med 2007; 8: 12-17.
31. Ursavas A, Ilcol YO, Nalci N, Karadag M, Ghrelin Ege E. leptin, adiponectin, and resistin levels in sleep apnea syndrome: role of obesity. Ann Thorac Med 2010; 5: 161-165.
32. Yamamoto Y, Fujiuchi S, Hiramatsu M, Nishigaki Y, Takeda A, Fujita Y et al. Resistin is closely related to systemic inflammation in obstructive sleep apnea. Respiration 2008; 76: 377-385.
33. Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest 2008; 134: 686-692.
34. Garcia JM, Sharafkhaneh H, Hirshkowitz M, Elkhatib R, Sharafkhaneh A. Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity. Respir Res 2011; 12: 80.
35. Harsch IA, Schahin SP, Bruckner K, Radespiel-Troger M, Fuchs FS, Hahn EG et al. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration 2004; 71: 252-259.
36. Harsch IA, Koebnick C, Wallaschofski H, Schahin SP, Hahn EG, Ficker JH et al. Resistin levels in patients with obstructive sleep apnoea syndrome-the link to subclinical inflammation? Med Sci Monit 2004; 10: CR510-CR515.
37. Sanner BM, Kollhosser P, Buechner N, Zidek W, Tepel M. Influence of treatment on leptin levels in patients with obstructive sleep apnoea. Eur Respir J 2004; 23: 601-604.
38. Barcelo A, Barbe F, Llompart E, de la Pena M, Duran-Cantolla J, Ladaria A et al. Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity. Am J Respir Crit Care Med 2005; 171: 183-187.
39. Carpagnano GE, Resta O, Pergola GD, Sabato R, Foschino Barbaro MP. The role of obstructive sleep apnea syndrome and obesity in determining leptin in the exhaled breath condensate. J Breath Res 2010; 4: 036003.
40. Lefebvre AM, Laville M, Vega N, Riou JP, van Gaal L, Auwerx J et al. Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes 1998; 47: 98-103.
41. Minocci A, Savia G, Lucantoni R, Berselli ME, Tagliaferri M, Calo G et al. Leptin plasma concentrations are dependent on body fat distribution in obese patients. Int J Obes Relat Metab Disord 2000; 24: 1139-1144.
42. Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S. Depot-and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 1997; 46: 342-347.
43. Maislin G, Ahmed MM, Gooneratne N, Thorne-Fitzgerald M, Kim C, Teff K et al. Single slice vs volumetric MR assessment of visceral adipose tissue: reliability and validity among the overweight and obese. Obesity (Silver Spring) 2012; e-pub ahead of print 7 March 2012.
44. Efron B, Tibshirani RJ. An Introduction to the Bootstrap, (Monographs on Statistics and Applied Probability, 57). Chapman and Hall: New York, 1993.
45. Myers RH, Montgomery DC. Response Surface Methodology, Process and Product Optimization Using Designed Experiments. John Wiley & Sons, Inc.: New York, 1995.
46. Arnardottir ES, Maislin G, Schwab RJ, Staley B, Benediktsdottir B, Olafsson I et al. The interaction of obstructive sleep apnea and obesity on the inflammatory markers C-reactive protein and interleukin-6: the Icelandic Sleep Apnea Cohort. Sleep 2012; 35: 921-932.
47. Schwab RJ, Pasirstein M, Pierson R, Mackley A, Hachadoorian R, Arens R et al. Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. Am J Respir Crit Care Med 2003; 168: 522-530.
48. Schwartz AR, Patil SP, Laffan AM, Polotsky V, Schneider H, Smith PL. Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proc Am Thorac Soc 2008; 5: 185-192.
49. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548-2556.
50. Shinohara E, Kihara S, Yamashita S, Yamane M, Nishida M, Arai T et al. Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med 1997; 241: 11-18.
51. Chiu M, Austin PC, Manuel DG, Shah BR, Tu JV. Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. Diabetes Care 2011; 34: 1741-1748.
52. Genta PR, Lorenzi-Filho G. Sleep apnoea in Asians and Caucasians: comparing apples and oranges. Eur Respir J 2011; 37: 1537-1538; author reply 1538-1539.
53. Lee RW, Vasudavan S, Hui DS, Prvan T, Petocz P, Darendeliler MA et al. Differences in craniofacial structures and obesity in Caucasian and Chinese patients with obstructive sleep apnea. Sleep 2010; 33: 1075-1080.
54. Conroy SM, Chai W, Lim U, Franke AA, Cooney RV, Maskarinec G. Leptin adiponectin, and obesity among Caucasian and Asian women. Mediators Inflamm 2011: 253580.
55. Mente A, Razak F, Blankenberg S, Vuksan V, Davis AD, Miller R et al. Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care 2010; 33: 1629-1634.
56. Thomas T, Burguera B, Melton III LJ , Atkinson EJ, O'Fallon WM, Riggs BL et al. Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women. Metabolism 2000; 49: 1278-1284.
57. Pack AI, Gislason T. Obstructive sleep apnea and cardiovascular disease: a perspective and future directions. Prog Cardiovasc Dis 2009; 51: 434-451.
58. Reinke C, Bevans-Fonti S, Drager LF, Shin MK, Polotsky VY. Effects of different acute hypoxic regimens on tissue oxygen profiles and metabolic outcomes. J Appl Physiol 2011; 111: 881-890.
59. Mehra R, Xu F, Babineau DC, Tracy RP, Jenny NS, Patel SR et al. Sleep-disordered breathing and prothrombotic biomarkers: cross-sectional results of the Cleveland Family Study. Am J Respir Crit Care Med 2010; 182: 826-833.
60. Dingli K, Coleman EL, Vennelle M, Finch SP, Wraith PK, Mackay TW et al. Evaluation of a portable device for diagnosing the sleep apnoea/hypopnoea syndrome. Eur Respir J 2003; 21: 253-259.
61. Iber C, Ancoli-Israel S, Chesson AL, Quan SF for the Americal Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology, and Technical Specification. 1st edn American Academy of Sleep Medicine: Westchester, IL, 2007.
62. Laskey MA. Dual-energy X-ray absorptiometry and body composition. Nutrition 1996; 12: 45-51.
63. Levendowski D, Steward D, Woodson BT, Olmstead R, Popovic D, Westbrook P. The impact of obstructive sleep apnea variability measured in-lab versus in-home on sample size calculations. Int Arch Med 2009; 2: 2.
64. Wittig RM, Romaker A, Zorick FJ, Roehrs TA, Conway WA, Roth T. Night-to-night consistency of apneas during sleep. Am Rev Respir Dis 1984; 129: 244-246.